What is the Impact Factor of Biochimica et Biophysica Acta-Reviews on Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Biochimica et Biophysica Acta-Reviews on Cancer is 11.2, ranking in quartile Q1 of Web of Science (SCIE).

Is Biochimica et Biophysica Acta-Reviews on Cancer indexed in Web of Science or Scopus?

Yes, Biochimica et Biophysica Acta-Reviews on Cancer is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 2.882 (Q1) and an H-index of 174.

Who publishes Biochimica et Biophysica Acta-Reviews on Cancer and what is the Article Processing Charge (APC)?

Biochimica et Biophysica Acta-Reviews on Cancer is published by Elsevier. The estimated Article Processing Charge (APC) is approximately $4,005 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Biochimica et Biophysica Acta-Reviews on Cancer?

The official ISO-4 abbreviation of Biochimica et Biophysica Acta-Reviews on Cancer is "BBA-REV CANCER" with common acronym "bbacan". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #766Top JournalReview JournalHybrid

Biochimica et Biophysica Acta-Reviews on Cancer

Acronym:bbacan

•

Abbreviation (ISO):BBA-REV CANCER

•

Identifier (ISSN):0304-419X(Print)/1879-2561(Online)

•

Publisher:Elsevier

Official Website Submission Portal Compare

Clarivate IF (2026)

11.2↑ +2.9

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Biochimica et Biophysica Acta-Reviews on Cancer

WoS Q1

Annual Impact Factor Metric

Current (2026):11.2

Scopus SJR & RankScopus Q1

2.882

#766

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

174

174 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

160articles/year

26.85% Gold OA•2.36% Original Research

Aims & Scope

BBA Reviews on Cancer covers the whole field of the biology and biochemistry of cancer, emphasizing oncogenes and tumor suppressor genes, growth-related cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mechanisms, genetics of human (mammalian) cancer, control of cell proliferation, genetic and molecular control of organismic development, rational anti-tumor drug design. In short, the journal presents critical invited reviews on new developments in cancer investigation at the molecular level.

Topics Covered (Recognized by AI)

BiologyGeneticsMedicineChemistryInternal MedicineBiochemistryOncology & Cancer ResearchCancer ResearchCell BiologyImmunologyPathology

Primary Research Areas

Medicine Biochemistry & Molecular Biology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank27/328

IndexSCIE

JCRSCIE2026

BIOPHYSICS

Rank4/81

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank31/333

IndexSCIE

JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank40/328

IndexSCIE

JCISCIE2026

BIOPHYSICS

Rank5/81

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank54/333

IndexSCIE

Category	Index	Rank	Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCRSCIE	27/328	Q1
BIOPHYSICS	JCRSCIE	4/81	Q1
ONCOLOGY	JCRSCIE	31/333	Q1
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCISCIE	40/328	Q1
BIOPHYSICS	JCISCIE	5/81	Q1
ONCOLOGY	JCISCIE	54/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF11.2

Articles / Year189

Total Citations180

2025

IF8.3

Articles / Year266

Total Citations1,634

2024

IF9.7

Articles / Year163

Total Citations2,843

2023

IF11.2

Articles / Year174

Total Citations5,430

2022

IF11.414

Articles / Year136

Total Citations5,299

Year	Impact Factor	Articles / Year	Total Citations
2026	11.2	189	180
2025	8.3	266	1,634
2024	9.7	163	2,843
2023	11.2	174	5,430
2022	11.414	136	5,299
2021	10.68	141	9,076
2020	7.365	134	10,319
2019	6.887	64	8,147
2018	8.22	74	6,172
2017	—	74	5,705
2016	—	60	4,402
2015	—	50	4,544

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #766Scopus Q1SCImago Profile

Scopus Coverage:1974-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

2.882

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

11.59

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,005 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,178

3-Year Documents447

Citable Documents446

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

GeneticsQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区BIOCHEMISTRY & MOLECULAR BIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Biochimica et Biophysica Acta-Reviews on Cancer (acronym: bbacan, abbr: BBA-REV CANCER, ISSN: 0304-419X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands. The periodical holds a Journal Impact Factor (JIF) of 11.2, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.882 (Q1), an H-index of 174.

The journal enforces rigorous peer evaluation with an average review speed of 4.9周, a publication frequency of Quarterly, an annual output of approximately 160 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,005 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.